← All stocks

Pasithea Therapeutics Corp.

KTTA Net buying
CIK 0001841330 #5937 in the set updated 19 Sep 2026
Bought (12 mo)
$203.00K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$203.00K
+$203.00K against sales at will

By person

6 insiders · 4 transactions
0.0×

Tiago Reis Marques holds only 0.0 times base salary in stock. $38.87K of shares against $533.61K in salary for 2025.

Salary from the company's own proxy. The shares are what Tiago Reis Marques last reported holding, valued at $0.53, the price Common Stock was last bought or sold at on the open market here, on 17 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
STEINMAN LAWRENCE
Director
$100.00K (1)
+$100.00K
199,691
$105.84K
+200.9%
Coastlands Capital LP entity
10% owner
$53.00K (1)
+$53.00K
3,835,035
$2.03M
+2.7%
Dumesnil Simon
Director
$25.00K (1)
+$25.00K
35,833
$18.99K
+1,333%
Marques Tiago
Chief Executive Officer
$25.00K (1)
+$25.00K
73,334
$38.87K
+79.0%
Leahy Emer
Director
33,333
$17.67K
Schneiderman Daniel H
Chief Financial Officer
26,667
$14.13K

No percentages here. This company's share count has moved by a factor of 26.4 over the window, from 1,266,427 to 33,414,448 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 60,000
History held since 22 Dec 2021